Hair Loss

Bosley and HairDX Team up with Breakthrough Genetic Testing for Male Baldness

Published in Medical Letter on the CDC and FDA, April 6th, 2008

Bosley, the world's most experienced hair restoration expert, today began offering a breakthrough genetic test for baldness from HairDX as part of its arsenal of hair loss solutions. The test can be accessed online at www.bosley.com, www.hairdx.com, or www.hairdx.com/spanish, and is the first test available to consumers as a marker to help assess their risk for developing Androgenetic Alopecia (male pattern baldness).

After assessing their genetic predisposition to baldness, consumers may elect to schedule a private, no-obligation educational consultation with a Bosley counselor, and if desired a personal evaluation with a Bosley physician. The consultation session will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2008-04-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry